Načítá se...
Risk impact of edoxaban in the management of stroke and venous thromboembolism
The new generation of target-specific oral anticoagulants is being prescribed for increasing numbers of patients at risk of stroke or venous thromboembolism (VTE). These drugs offer valuable benefits due to fast onset anticoagulation, a fixed anticoagulation effect (allowing administration of specif...
Uloženo v:
| Vydáno v: | Vasc Health Risk Manag |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4986674/ https://ncbi.nlm.nih.gov/pubmed/27563246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S94679 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|